Cartesian Therapeutics In... (RNAC)

NASDAQ: RNAC · Real-Time Price · USD

12.68

0.41 (3.34%)

At close: May 02, 2025, 2:59 PM

Cartesian Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	212.61M	76.91M	106.44M	114.06M	138.69M	90.17M	37.4M	70.7M	58.73M
Short-Term Investments	n/a	n/a	28.16M	14M	n/a	n/a	n/a	25.94M	25.48M
Long-Term Investments	2M	2M	2M	2M	1.75M	1.38M	279K	n/a	n/a
Other Long-Term Assets	2.19M	1.38M	1.34M	1.47M	n/a	n/a	-1	329K	438K
Receivables	872K	8.85M	9.86M	9.91M	7.22M	5M	n/a	63K	215K
Inventory	n/a	n/a	n/a	n/a	1M	n/a	n/a	n/a	n/a
Other Current Assets	3.14M	4.97M	3.39M	n/a	n/a	279K	n/a	1.98M	78K
Total Current Assets	216.63M	90.73M	148.14M	144.44M	151.34M	96.67M	42.08M	98.68M	86.82M
Property-Plant & Equipment	15.45M	12.18M	14.41M	11.97M	12.34M	1.52M	2.13M	2.09M	2.05M
Goodwill & Intangibles	198.76M	198.76M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	218.4M	214.32M	17.75M	15.44M	14.09M	2.9M	2.41M	2.42M	2.48M
Total Assets	435.02M	305.05M	165.89M	159.88M	165.44M	99.57M	44.48M	101.1M	89.3M
Account Payables	288K	3.15M	316K	224K	443K	500K	1.1M	1.61M	3.88M
Deferred Revenue	n/a	2.31M	593K	53.88M	72.05M	1.67M	959K	787K	1.84M
Short-Term Debt	2.85M	n/a	8.48M	5.96M	n/a	18.91M	21.39M	n/a	4.07M
Other Current Liabilities	19.84M	56.19M	19.68M	14.71M	5.1M	22.51M	9.2M	5.82M	2.37M
Total Current Liabilities	22.98M	68.21M	25.08M	72.25M	81.55M	34.94M	35.14M	10.97M	13.71M
Long-Term Debt	n/a	-322.08M	17.79M	19.67M	24.79M	n/a	n/a	21.04M	7.98M
Other Long-Term Liabilities	418.85M	342.62M	19.14M	25.42M	28.71M	41.55M	938K	1.35M	222K
Total Long-Term Liabilities	418.85M	677.02M	46.98M	65.11M	101.89M	56.23M	14.76M	38.31M	20.64M
Total Liabilities	441.82M	745.23M	72.06M	137.36M	183.44M	91.17M	49.9M	49.29M	34.34M
Total Debt	13.98M	10.96M	37.92M	35.28M	35.35M	19.28M	21.39M	21.04M	12.04M
Common Stock	3K	16K	15K	12K	11K	9K	3K	3K	1K
Retained Earnings	-692.07M	-614.65M	-394.94M	-430.32M	-404.63M	-335.75M	-280.4M	-216.9M	-151.58M
Comprehensive Income	-4.62M	-4.6M	-4.56M	-4.57M	-4.56M	-4.52M	-4.56M	-4.42M	-4.59M
Shareholders Equity	-6.8M	-440.18M	93.83M	22.52M	-18.01M	8.4M	-5.42M	51.81M	54.96M
Total Investments	2M	2M	30.16M	16M	1.75M	1.38M	279K	25.94M	25.48M